Current Report · Items 8.01, 9.01 · 8-K

Definitive Healthcare Corp.

DHNASDAQEQUITYCurrent

Other Events

Filed Sep 2, 2026Accepted Sep 2, 2026, 9:16 AM EDTCIK 1861795Accession 0001193125-26-379460

Company context

Definitive Healthcare is a data and analytics company focused on the business side of healthcare. The healthcare market is complex - our data makes it clearer. We cut through the noise to deliver the insights that healthcare organizations and companies need to make smarter, faster, more strategic decisions. Because when our customers succeed, healthcare gets better for everyone. Learn more at definitivehc.com.

Current securities

DHNASDAQ · EQUITY · Current

Recent company filings

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events

Item 8.01 Other Events. On September 2, 2026, Definitive Healthcare Corp. (the “Company”) issued a press release announcing that the Special Committee (the “Special Committee”) of the Board of Directors of the Company received a non-binding proposal from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company’s Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent and Jason Krantz, the Company’s founder and Executive Chairman for an all cash-purchase price of $1.02 per share of Class A Common Stock and an equivalent amount per Definitive OpCo Unit. A copy of the press release is attached hereto as Exhibits 99.1 and incorporated herein by reference.

Filed exhibits (1)

EX-99.1 (by filename) dh-ex99_1.htm

EX-99.1 2 dh-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International September 2, 2026 Framingham, Mass., Sept. 2, 2026 (GLOBE NEWSWIRE) - The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company’s Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent or Jason Krantz, the Company’s founder and Executive Chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit. The Special Committee, which is composed entirely of disinterested and…

Open exhibit ↗

Get the free weekly BCS email.